Product
5-Fluorouracil + Leucovorin
1 clinical trial
2 indications
Indication
Gastric Esophageal CancerIndication
Stomach CancerClinical trial
A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal CancersStatus: Recruiting, Estimated PCD: 2028-04-01